How ZYN Pouches Work: Absorption, Effects & Strengths

ZYN pouches deliver nicotine through the lining of your mouth, not your lungs. You tuck a small, tobacco-free pouch between your upper lip and gum, and saliva dissolves the nicotine out of a plant-fiber filler. That nicotine then passes through the oral mucosa into tiny blood vessels beneath the surface, reaching your brain within minutes. The process is slower and produces a flatter nicotine curve than smoking a cigarette, but at higher pouch strengths, the total amount of nicotine your body absorbs can be comparable.

What Is Actually Inside the Pouch

ZYN pouches contain no tobacco leaf. The nicotine is either extracted from tobacco and purified or synthesized in a lab. Chemical analysis of nicotine pouches across multiple brands found that nine out of fourteen used synthetic nicotine, identifiable by its hydrogen isotope signature. That synthetic nicotine is virtually all S-nicotine, the same molecular form found in tobacco plants, typically making up more than 99% of the total nicotine content.¹ Tobacco-derived nicotine is similarly dominated by S-nicotine, at roughly 99.3%, so in practice the two are chemically identical once purified to that level.²

The rest of the pouch is mostly microcrystalline cellulose, a plant-derived fiber that serves as the filler and controls how quickly nicotine dissolves out. Manufacturers can adjust the crystalline structure of this filler to speed up or slow down nicotine release. The more amorphous the cellulose, the more moisture it absorbs, which softens the material and lets nicotine molecules move through it more easily. Flavoring agents, sweeteners, pH adjusters, and a small amount of water or humectant round out the ingredient list. No combustion happens, and there is no smoke or vapor.

How Nicotine Crosses Through Your Gum Tissue

The speed at which nicotine passes through the oral lining depends heavily on pH. Nicotine is a weak base, and at a higher pH it sheds its electrical charge to become what chemists call the “free-base” form. This uncharged version slips across cell membranes far more easily than the charged version. At a pH above roughly 8, a much larger fraction of the nicotine in the pouch exists in free-base form, which allows it to pass through the mucosal tissue faster and reach the bloodstream at higher concentrations.³ At lower pH, more nicotine stays charged and absorption slows down.

This is why ZYN and similar pouches include buffering agents like sodium carbonate or sodium bicarbonate. These ingredients raise the local pH inside the pouch and at the tissue surface, pushing more nicotine into free-base form. It is also why you feel a tingling or slight burn when you first place the pouch: the alkaline environment is mildly irritating to the tissue. That sensation usually fades after a few minutes as saliva dilutes the buffering agents.

How Absorption Compares to Smoking

The pharmacokinetic profile of a nicotine pouch looks very different from a cigarette, even when the total nicotine dose is similar. A meta-analysis pooling data from multiple trials found that cigarettes produce peak blood nicotine levels within about five to eight minutes, while pouches take somewhere between 20 and 65 minutes to peak.⁴ The peak itself is also lower with pouches at most strengths. With 4 mg pouches, the most commonly used strength, peak nicotine concentration reached about 69% of what a cigarette delivers. But when you look at total nicotine exposure over time rather than just the peak, 4 mg pouches delivered a similar overall amount of nicotine to the bloodstream as cigarettes.⁴

Compared to traditional smokeless tobacco like moist snuff, higher-strength pouches perform surprisingly well despite containing far less total nicotine per pouch. A pharmacokinetic study found that ZYN 8 mg pouches produced nearly identical blood nicotine curves to a brand of American moist snuff containing 18 mg of nicotine per serving. The two higher ZYN doses tested, 6 mg and 8 mg, delivered nicotine as quickly and to a similar total extent as existing smokeless products.⁵ The reason a pouch with less nicotine can match or approach a product with more has to do with formulation: the buffering, filler design, and moisture content are all engineered to maximize how much of that labeled nicotine actually makes it into your blood.

Pouch Strengths and Why the Label Can Be Misleading

ZYN pouches in the United States are most commonly sold in 3 mg and 6 mg versions, referring to the total nicotine content per pouch. In some European markets, strengths range more widely, and other nicotine pouch brands go higher. It is natural to assume that a 6 mg pouch will produce roughly double the blood nicotine level of a 3 mg pouch. It does not always work that way. A randomized trial measuring plasma nicotine after pouch use found that blood nicotine concentration was not straightforwardly tied to the labeled nicotine content of the pouch.⁶

Several factors explain the disconnect. The pH of the pouch, the type of cellulose filler, how much moisture is present, how long you keep it in, and how much saliva you produce all affect how much nicotine dissolves and how much of that dissolved nicotine crosses the tissue barrier. Two pouches with the same labeled strength from different brands can deliver meaningfully different amounts of nicotine to your bloodstream. Even the same pouch used by two different people will produce different plasma levels depending on individual saliva flow, tissue thickness, and placement habits. If you are switching brands or strengths, the numbers on the label give you a general direction but not a precise prediction of your experience.

What Nicotine Does Once It Reaches the Brain

Once nicotine enters the bloodstream, it crosses into the brain within seconds. There it binds to nicotinic acetylcholine receptors, which are found throughout the central nervous system. These receptors normally respond to acetylcholine, a neurotransmitter involved in attention, arousal, and muscle control. When nicotine activates them instead, it triggers the release of several other neurotransmitters including dopamine, serotonin, norepinephrine, and glutamate.⁷

The dopamine release is the part that drives the rewarding sensation. Nicotine activates receptors on dopamine-producing neurons in a region called the ventral tegmental area, which sends dopamine to the nucleus accumbens, a reward center. The result is a brief feeling of pleasure, alertness, and focus. At the same time, nicotine shifts the balance between inhibitory and excitatory signaling in a way that amplifies that dopamine release, which is a key piece of why nicotine is habit-forming.⁷ Because pouches deliver nicotine more gradually than cigarettes, the subjective “hit” is gentler, but the same reward circuitry is being activated.

Cardiovascular Effects and What Happens When You Stop

Nicotine, regardless of how it enters your body, raises heart rate and can influence blood pressure through stimulation of the sympathetic nervous system. A Swedish cohort study tracked people who quit using nicotine pouches and tobacco, measuring their cardiovascular markers over 12 weeks. During the first week after quitting, heart rate dropped by an average of about six beats per minute. That reduction persisted in smaller increments for several more weeks before leveling off.⁸ Diastolic blood pressure dipped briefly in the first week, then returned to baseline. Systolic blood pressure, somewhat counterintuitively, crept upward by a few points over the 12 weeks after quitting, possibly reflecting weight gain or other metabolic adjustments that often accompany nicotine cessation.⁸

The heart rate finding is worth paying attention to if you are a regular pouch user. A chronically elevated resting heart rate is a recognized cardiovascular risk factor. The study’s results suggest that the nicotine in pouches does maintain a measurably higher heart rate during active use, and that effect reverses after stopping.

What Pouches Do to Your Mouth

The most visible local effect is tissue change right where you place the pouch. Clinical case reports have documented gum recession and white, leathery patches called leukoplakia at the exact sites of habitual pouch placement in otherwise healthy young men. The combination of mechanical pressure and chemical exposure from the alkaline, nicotine-containing pouch appears to cause localized trauma to the gum tissue and oral lining.⁹ A pilot study looking at oral mucosal changes in pouch users found similar white, leathery changes in five participants, all at the sites where pouches were typically placed.¹⁰

There is some encouraging data on the other side. When Swedish snus users with pre-existing mucosal lesions switched to tobacco-free nicotine pouches, their oral tissue improved over time, with a reduction in visible lesions by the end of the study period.¹¹ That suggests nicotine pouches are gentler on oral tissue than snus, even if they are not without effect. Rotating the placement site in your mouth is a practical way to reduce the cumulative exposure any one spot receives.

Beyond visible tissue changes, pouch use also appears to shift the bacterial community in your mouth. A study comparing pouch users to non-tobacco users found differences in the types of bacteria colonizing the oral mucosa, with certain species elevated and others reduced in pouch users. The overall diversity of the microbial community was somewhat narrower in the pouch group.¹² The long-term health significance of these microbial shifts is not yet clear, but reduced microbial diversity in the mouth has been associated with periodontal problems in other research contexts.

Toxicant Levels Compared to Cigarettes and Snus

One of the strongest arguments for nicotine pouches over traditional tobacco products is the toxicant profile. Because the pouches contain no tobacco leaf, they lack most of the harmful compounds generated by curing, fermenting, and especially burning tobacco. A chemical analysis comparing nicotine pouches to snus found that the pouches had lower levels of ten harmful or potentially harmful constituents, with an additional thirteen either comparable or undetectable.¹³

Tobacco-specific nitrosamines, the carcinogens most associated with smokeless tobacco cancer risk, are present in nicotine pouches only at trace levels. A screening of nicotine pouch products detected these compounds in 26 products, but the amounts were mostly at or below the limits of what instruments could reliably measure. The highest levels found were far below what cigarettes and snus typically contain.¹⁴ The traces that do show up likely come from impurities in tobacco-derived nicotine or from ambient contamination during manufacturing. Products using high-purity synthetic nicotine would be expected to have even lower levels, though this has not been systematically confirmed across all brands.

How Flavor Changes the Experience

Most ZYN pouches are flavored, and the flavor does more than make the product taste better. Randomized studies comparing flavored and unflavored versions of the same pouch found that flavor did not significantly change how much nicotine was absorbed for most product types. The exception was certain moist mint varieties, which showed differences in absorption that prevented the researchers from concluding the flavored and unflavored versions were equivalent. Users rated flavored pouches higher for satisfaction and liking, and were more likely to say they would use them again.¹⁵

Menthol, one of the most common flavoring agents in nicotine products, deserves particular attention. Laboratory experiments using porcine oral tissue, which closely resembles human oral mucosa, found that menthol significantly increased the rate at which nicotine penetrated through the tissue. Even a brief 30-minute menthol exposure boosted nicotine flux, and the effect persisted for hours afterward. The mechanism appears to involve menthol loading into a superficial layer of the tissue and continuing to enhance permeability from that reservoir.¹⁶ The same study found that menthol also increased penetration of tobacco-specific carcinogens, though for tobacco-free pouches with negligible carcinogen content, that concern is much less relevant. The practical implication is that a menthol or mint ZYN pouch may deliver nicotine slightly faster or more efficiently than an unflavored one, even at the same labeled strength.

S-Nicotine Versus Racemic Nicotine

Not all synthetic nicotine is created equal. The synthesis process can produce a 50/50 mix of S-nicotine and R-nicotine (called a racemic mixture) or be refined to nearly pure S-nicotine, the biologically active form. A crossover trial comparing pouches with more than 99% S-nicotine to pouches with racemic nicotine found that the S-nicotine pouches produced substantially higher blood nicotine levels, with peak plasma concentrations roughly 74% higher. Despite that large pharmacokinetic difference, users rated both types similarly for product liking and withdrawal relief, though they reported more unpleasant side effects with the pure S-nicotine version.¹⁷

This matters because regulatory frameworks are only beginning to distinguish between these forms of synthetic nicotine. A pouch labeled “6 mg nicotine” that uses racemic nicotine effectively delivers roughly half as much active nicotine as one using pure S-nicotine, since R-nicotine has much weaker activity at the receptors that matter. As more brands enter the market with varying purities, the strength number on the label becomes even less reliable as a guide to what you will actually feel.

Risks for Adolescents and Young Adults

Nicotine pouches have gained traction among younger users, and the developing brain responds to nicotine differently than an adult brain. During adolescence and into the early twenties, the prefrontal cortex and reward circuits are still maturing. Nicotine exposure during this window disrupts the normal development of dopamine and serotonin systems, leading to lasting structural and functional changes. The effects include heightened sensitivity to nicotine’s rewarding properties, reduced perception of its unpleasant side effects, and milder withdrawal symptoms, all of which make it easier to develop a habit and harder to recognize it as a problem.¹⁸

These nicotine-induced changes can persist into adulthood, with potential long-term effects on attention, impulse control, and vulnerability to anxiety and depression. The cardiovascular implications are less well studied in young users specifically, but given nicotine’s known effects on sympathetic nervous system activation and blood vessel function in adults, there are credible concerns that early and sustained exposure could interfere with normal cardiovascular maturation.¹⁸ The discreet, odorless format of pouches makes them particularly easy to use undetected in school or home settings, which compounds the concern. The lower toxicant profile compared to cigarettes does not change the fact that nicotine itself, at this stage of brain development, carries real risks that are separate from the question of tar and carcinogens.

1
Microchemical Journal. Comprehensive chemical characterization of nicotine pouches
2
PLoS ONE. Analysis and differentiation of tobacco-derived and synthetic nicotine products: Addressing an urgent regulatory issue
3
PubMed Central. Evaluation of Factors Impacting Nicotine Permeation in Oral Nicotine Pouch Products
4
PubMed Central. Nicotine pouch pharmacokinetics compared to smoked tobacco: A systematic review and meta-analysis
5
Nicotine & Tobacco Research. Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff
6
PubMed Central. A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette
7
PubMed Central. Cognitive Effects of Nicotine: Recent Progress
8
PubMed Central. Cardiovascular and metabolic changes following 12 weeks of tobacco and nicotine pouch cessation: a Swedish cohort study
9
PubMed Central. Localized gingival recession and leukoplakia associated with nicotine pouch use: two clinical case reports
10
PubMed Central. The Effects of Nicotine Pouches and E-Cigarettes on Oral Microbes: A Pilot Study
11
PubMed Central. The effect of a non-tobacco-based nicotine pouch on mucosal lesions caused by Swedish smokeless tobacco (snus)
12
PubMed Central. Oral Nicotine Pouch Use and Associations with Periodontal Status and Salivary Microbiome Dysbiosis
13
PubMed. Chemical characterization of tobacco-free “modern” oral nicotine pouches and their position on the toxicant and risk continuums
14
Tobacco Control. Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches
15
PubMed. Randomized studies assessing the effect of flavor on pharmacokinetic and subjective parameters for dry and moist nicotine pouches
16
Nicotine & Tobacco Research. Effect of menthol on the penetration of tobacco carcinogens and nicotine across porcine oral mucosa ex vivo
17
Nicotine & Tobacco Research. Evaluating the Role of Nicotine Stereoisomer on Nicotine Pouch Abuse Liability: A Randomized Crossover Trial
18
PubMed Central. Nicotine pouches and youth: emerging patterns and potential cardiovascular risks